-

Phibro Animal Health Corporation Releases Third Annual ESG Report: Connections that Advance Animal Health, Nutrition and Sustainability

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) proudly announces its third annual Environmental, Social and Governance (ESG) Report, highlighting 2023 achievements. At Phibro, the connections between people, animals and the planet drive us to optimize animal health and nutrition for better lives and a sustainable world.

“Phibro’s business segments naturally align with today’s ESG and corporate responsibility mindset,” said Jack Bendheim, President, CEO and Chairman of the Board. “We help farmers become more efficient and sustainable by preventing animal disease, reducing waste and conserving resources. This results in a safer, more affordable food supply for society.”

Recent research confirms that controlling livestock disease benefits economic, environmental, and social sustainability, aligning with the UN's Sustainable Development Goals (SDGs) for 2030. Our ESG Report offers insights into the global impact of animal health on the environment, economies, and society, emphasizing the importance of the One Health approach, which recognizes the interconnected health of people, animals, and the planet.

In 2023, Phibro’s efforts reinforce that keeping livestock healthy can significantly reduce greenhouse gas (GHG) emissions. Preventing diseases lowers the carbon footprint of raising livestock and boosts food production efficiency, helping to mitigate climate change while ensuring food security.

Our focus on disease prevention and animal health and nutrition helps reduce the economic burden on farmers, allowing investment in sustainable practices. Healthy animals need fewer resources, such as feed and water, conserving natural resources and reducing waste. These practices align with our One Health commitment, promoting a balance that benefits all life on Earth.

Phibro’s dedication goes beyond business goals. We recognize our responsibility to communities and the planet, promoting animal health and nutrition intertwined with social and economic equity. By enhancing farmers’ livelihoods and ensuring a stable food supply, we help reduce poverty and malnutrition, key targets of the UN’s SDGs.

Moving forward, Phibro remains committed to creating meaningful connections among people, animals, and the planet. Our dedication to sustainability and ethical growth guides our actions, ensuring positive contributions to the world we share.

For more information and to read the full 2023 ESG Report, please visit https://www.pahc.com/responsibility/.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians, nutritionists, and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit www.pahc.com.

Contacts

Glenn David
Chief Financial Officer, Phibro Animal Health Corporation
+1-201-329-7300
investor.relations@pahc.com

Phibro Animal Health Corporation

NASDAQ:PAHC

Release Versions

Contacts

Glenn David
Chief Financial Officer, Phibro Animal Health Corporation
+1-201-329-7300
investor.relations@pahc.com

More News From Phibro Animal Health Corporation

Phibro Animal Health Corporation to Participate in Bank of America 2026 Virtual Animal Health Summit

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2026 Virtual Animal Health Summit. Chief Financial Officer, Glenn David; Chief Operating Officer, Larry Miller and Executive Vice President, Corporate Strategy and CEO designate Daniel Bendheim will address financial analysts and investors on Thursday, February 26, 2026, at 10:45 AM ET. The live audio presentation will be available on the Phibro Animal Healt...

Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2025, and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended December 31, 2025 (compared to the three months ended December 31, 2024): Net sales of $373.9 million, an increase of $64.6 million, or 21% Net income of $27.5 million, an increase of $24.3 million Dil...

Phibro Animal Health Corporation Declares Quarterly Dividend

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 25, 2026, to stockholders of record at the close of business on March 4, 2026. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with liv...
Back to Newsroom